Market Closed -
OTC Markets
20:59:54 10/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.003
USD
|
+50.00%
|
|
+25.00%
|
-25.00%
|
Fiscal Period: February |
2018
|
2019
|
2020
|
2022
|
2023
|
---|
Capitalization
1 |
1.796
|
9.7
|
4.316
|
1.458
|
0.964
|
Enterprise Value (EV)
1 |
1.994
|
9.899
|
4.272
|
1.659
|
1.275
|
P/E ratio
|
-
|
-1,350
x
|
-55.3
x
|
0.12
x
|
0.19
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
70.1
x
|
83.2
x
|
165
x
|
-
|
-
|
EV / Revenue
|
77.8
x
|
84.9
x
|
164
x
|
-
|
-
|
EV / EBITDA
|
12,085
x
|
-2,835
x
|
-528
x
|
-
|
-
|
EV / FCF
|
-
|
-
|
18,397,247
x
|
-
|
-305,791
x
|
FCF Yield
|
-
|
-
|
0%
|
-
|
-0%
|
Price to Book
|
-
|
-1,350
x
|
103
x
|
-0.19
x
|
-0.34
x
|
Nbr of stocks (in thousands)
|
898,189
|
898,189
|
165,999
|
265,000
|
401,667
|
Reference price
2 |
0.002000
|
0.0108
|
0.0260
|
0.005500
|
0.002400
|
Announcement Date
|
26/12/19
|
26/12/19
|
04/01/21
|
14/06/23
|
14/06/23
|
Fiscal Period: February |
2018
|
2019
|
2020
|
2022
|
2023
|
---|
Net sales
1 |
0.0256
|
0.1166
|
0.0261
|
-
|
-
|
EBITDA
1 |
0.000165
|
-0.003492
|
-0.008088
|
-
|
-
|
EBIT
1 |
-0.000501
|
-0.007488
|
-0.0141
|
-0.1988
|
-0.1459
|
Operating Margin
|
-1.96%
|
-6.42%
|
-53.95%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.000501
|
-0.007488
|
-0.2498
|
10.54
|
3.822
|
Net income
1 |
-0.000501
|
-0.007488
|
-0.2498
|
10.54
|
3.822
|
Net margin
|
-1.96%
|
-6.42%
|
-957.16%
|
-
|
-
|
EPS
2 |
-
|
-0.000008
|
-0.000470
|
0.0449
|
0.0123
|
Free Cash Flow
|
-
|
-
|
0.2322
|
-
|
-4.17
|
FCF margin
|
-
|
-
|
889.72%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/12/19
|
26/12/19
|
04/01/21
|
14/06/23
|
14/06/23
|
Fiscal Period: February |
2018
|
2019
|
2020
|
2022
|
2023
|
---|
Net Debt
1 |
0.2
|
0.2
|
-
|
0.2
|
0.31
|
Net Cash position
1 |
-
|
-
|
0.04
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1,197
x
|
-56.76
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
0.23
|
-
|
-4.17
|
ROE (net income / shareholders' equity)
|
-
|
176%
|
-1,427%
|
-
|
-80.8%
|
ROA (Net income/ Total Assets)
|
-
|
-2.37%
|
-7.27%
|
-
|
-67.4%
|
Assets
1 |
-
|
0.3155
|
3.435
|
-
|
-5.672
|
Book Value Per Share
2 |
-
|
-0
|
0
|
-0.0300
|
-0.0100
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
Capex
1 |
0.01
|
-
|
-
|
-
|
-
|
Capex / Sales
|
46.83%
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/12/19
|
26/12/19
|
04/01/21
|
14/06/23
|
14/06/23
|
|
1st Jan change
|
Capi.
|
---|
| -25.00% | 2.21M | | +30.38% | 684B | | +26.51% | 568B | | -4.36% | 361B | | +19.30% | 329B | | +3.73% | 284B | | +16.70% | 240B | | +8.78% | 208B | | -7.93% | 200B | | +7.68% | 166B |
Other Pharmaceuticals
|